Skip to main navigation Skip to search Skip to main content

High-throughput screening of dendrimer-binding drugs

  • Libo Zhao
  • , Qinglin Wu
  • , Yiyun Cheng*
  • , Jiahai Zhang
  • , Jihui Wu
  • , Tongwen Xu
  • *Corresponding author for this work
  • University of Science and Technology of China
  • East China Normal University

Research output: Contribution to journalArticlepeer-review

Abstract

A convenient approach for the high-throughput screening of dendrimer-binding drugs by NMR techniques including saturation transfer difference (STD) NMR and Hadamard-encoded nuclear Overhauser effect measurements is presented. The screening results for insoluble drugs show that phenylbutazone and sulfamethoxazole prefer to localize in the interior pockets of dendrimer, while mycophenolic acid mostly binds on the dendrimer surface, and noncharged insoluble drugs like trimethoprim and primidone do not interact with dendrimers. In another path for soluble drugs, n-butanoic acid and dimethylformamide are screened as dendrimer-binding compounds from a screening pool containing eight soluble compounds by STD NMR. The screening of dendrimer-binding insoluble or soluble compounds can be finished within an hour.

Original languageEnglish
Pages (from-to)13182-13184
Number of pages3
JournalJournal of the American Chemical Society
Volume132
Issue number38
DOIs
StatePublished - 29 Sep 2010

Fingerprint

Dive into the research topics of 'High-throughput screening of dendrimer-binding drugs'. Together they form a unique fingerprint.

Cite this